サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1608797

ファーマコビジランスと医薬品安全性ソフトウェアの世界市場レポート 2024年

Pharmacovigilance And Drug Safety Software Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ファーマコビジランスと医薬品安全性ソフトウェアの世界市場レポート 2024年
出版日: 2024年12月09日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ファーマコビジランスと医薬品安全性ソフトウェア市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR13.0％で36億8,000万米ドルに成長します。予測期間中に予想される成長は、医薬品副作用（ADR）発生率の上昇、ファーマコビジランス業務のグローバリゼーション、医薬品安全規制の複雑化、新薬や治療法の開発の急増、ADR報告件数の増加など、いくつかの要因に起因すると考えられます。この期間を形成すると予想される主要動向には、自動化とAIの統合、クラウドベースのソリューションの採用、継続的な技術革新、さまざまな技術の進歩、医療の継続的なデジタル化などがあります。

個別化医療に対する需要の高まりが、今後数年間のファーマコビジランスと医薬品安全性ソフトウェア市場の成長を促進すると予測されます。精密医療としても知られる個別化医療は、患者一人ひとりの特性に基づいて医療上の意思決定や治療をカスタマイズする医療アプローチです。この需要の高まりは、治療成果の向上、予防と早期発見の重視、費用対効果の改善など、いくつかの要因に影響されています。ファーマコビジランスと医薬品安全性ソフトウェアは、個別化医療の成功に極めて重要な役割を果たします。薬理遺伝学、リアルタイムのデータ分析、市販後調査、個別化された薬剤情報などを統合することで、これらのツールは個別化治療の安全性と有効性を高めると同時に、強固なリスク管理戦略をサポートし、倫理的配慮に対処します。例えば、2024年2月、米国の非営利団体である個別化医療連合（Personalized Medicine Coalition）は、2023年にFDAが希少疾患患者向けに16の新規個別化治療を承認したと報告しました。その結果、個別化医療に対する需要の高まりがファーマコビジランスと医薬品安全性ソフトウェア市場の成長を牽引しています。

ファーマコビジランスと医薬品安全性ソフトウェア市場の主要企業は、クラウドベースのデータレイクプラットフォームなどの革新的な技術を開発し、患者の安全性を向上させ、有害事象をより効果的にモニタリングし、臨床検査や医療機器の市販後調査における規制遵守を強化しています。クラウドベースのデータレイクプラットフォームは、組織が膨大な量の構造化データと非構造化データを保存、管理、分析できるスケーラブルな集中ストレージシステムとして機能します。リアルタイムのデータアクセスを提供し、先進的分析やAI/MLワークロードをサポートします。例えば、米国のバイオテクノロジー企業であるThermo Fisher Scientificは、2023年12月、臨床研究登録内のファーマコビジランスプロセスを強化するために設計された独自のクラウドベースのデータレイクプラットフォームであるCorEvidenceを発表しました。このプラットフォームは、特に承認後の安全性検査における症例処理と安全性データ管理を最適化することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界のファーマコビジランスと医薬品安全性ソフトウェア市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のファーマコビジランスと医薬品安全性ソフトウェア市場の実績：規模と成長、2018～2023年
  • 世界のファーマコビジランスと医薬品安全性ソフトウェア市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界のファーマコビジランスと医薬品安全性ソフトウェア市場：ソフトウェアタイプ別、実績と予測、2018～2023年、2023～2028年、2033年
  • 有害事象報告ソフトウェア
  • 医薬品安全性監査ソフトウェア
  • 問題追跡ソフトウェア
  • 完全統合ソフトウェア
  • 世界のファーマコビジランスと医薬品安全性ソフトウェア市場：展開方法別、実績と予測、2018～2023年、2023～2028年、2033年
  • オンプレミス
  • クラウドベース
  • 世界のファーマコビジランスと医薬品安全性ソフトウェア市場：エンドユーザー別、実績と予測、2018～2023年、2023～2028年、2033年
  • 製薬とバイオテクノロジー企業
  • 契約研究機関
  • ビジネスプロセスアウトソーシング企業
  • その他

第7章 地域別・国別分析

  • 世界のファーマコビジランスと医薬品安全性ソフトウェア市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界のファーマコビジランスと医薬品安全性ソフトウェア市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ファーマコビジランスと医薬品安全性ソフトウェア市場：競合情勢
  • ファーマコビジランスと医薬品安全性ソフトウェア市場：企業プロファイル
    • Accenture plc
    • International Business Machines Corporation
    • Deloitte Touche Tohmatsu Limited
    • Oracle Corporation
    • Capgemini SE

第31章 その他の大手企業と革新的企業

  • Cognizant Technology Solutions
  • IQVIA
  • Wipro Limited
  • Genpact
  • Parexel Academy
  • PharmaLex
  • Indegene Limited
  • RXLogix
  • Sarjen Systems Pvt Ltd
  • Anju Software Inc.
  • Ennov Group
  • EXTEDO GmbH
  • ArisGlobal
  • AB Cube
  • Clinevo Technologies

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

目次
Product Code: r20314

Pharmacovigilance and drug safety software comprises a suite of digital tools aimed at monitoring, analyzing, and reporting adverse drug reactions (ADRs) and other safety-related information linked to pharmaceuticals and medical products. This software is essential for ensuring patient safety and maintaining regulatory compliance throughout a drug's lifecycle, from development to post-marketing surveillance.

The primary types of pharmacovigilance and drug safety software include adverse event reporting software, drug safety audit software, issue tracking software, and fully integrated software solutions. Adverse event reporting software specifically focuses on tracking, documenting, and managing adverse events associated with pharmaceutical products or medical devices. These solutions are available in both on-premise and cloud-based delivery modes and are utilized by a variety of end users, including pharmaceutical and biotechnology companies, contract research organizations, business process outsourcing firms, and others.

The pharmacovigilance and drug safety software market research report is one of a series of new reports from The Business Research Company that provides pharmacovigilance and drug safety software market statistics, including pharmacovigilance and drug safety software industry global market size, regional shares, competitors with a pharmacovigilance and drug safety software market share, detailed pharmacovigilance and drug safety software market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacovigilance and drug safety software industry. This pharmacovigilance and drug safety software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmacovigilance and drug safety software market size has grown rapidly in recent years. It will grow from $2.00 billion in 2023 to $2.26 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%. The growth observed during the historical period can be attributed to several factors, including a rising demand for pharmacovigilance and drug safety software, an increasing need for advanced pharmacovigilance solutions, escalating healthcare expenditures, a growing prevalence of chronic diseases, and heightened demand for specialized pharmacovigilance software.

The pharmacovigilance and drug safety software market size is expected to see rapid growth in the next few years. It will grow to $3.68 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%. The anticipated growth during the forecast period can be attributed to several factors, including a rise in the incidence of adverse drug reactions (ADRs), the globalization of pharmacovigilance practices, increasing complexity in drug safety regulations, a surge in the development of new drugs and therapies, and a growing number of reported ADRs. Key trends expected to shape this period include the integration of automation and AI, the adoption of cloud-based solutions, ongoing technological innovations, advancements in various technologies, and a continued digitalization of healthcare.

The increasing demand for personalized medicine is projected to drive growth in the pharmacovigilance and drug safety software market in the coming years. Also known as precision medicine, personalized medicine is a healthcare approach that customizes medical decisions and treatments based on the unique characteristics of each patient. This growing demand is influenced by several factors, including enhanced treatment outcomes, a focus on prevention and early detection, and improved cost-effectiveness. Pharmacovigilance and drug safety software play a crucial role in the success of personalized medicine. By integrating pharmacogenetics, real-time data analysis, post-marketing surveillance, and personalized medication information, these tools enhance the safety and efficacy of individualized treatments while supporting robust risk management strategies and addressing ethical considerations. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a significant increase from six in 2022. Consequently, the rising demand for personalized medicine is driving growth in the pharmacovigilance and drug safety software market.

Leading companies in the pharmacovigilance and drug safety software market are developing innovative technologies, such as cloud-based data lake platforms, to improve patient safety, monitor adverse events more effectively, and enhance regulatory compliance in clinical trials and post-market surveillance of medical devices. A cloud-based data lake platform serves as a scalable, centralized storage system that allows organizations to store, manage, and analyze vast amounts of structured and unstructured data. It provides real-time data access and supports advanced analytics as well as AI/ML workloads. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology firm, launched CorEvidence, a proprietary cloud-based data lake platform designed to enhance pharmacovigilance processes within clinical research registries. This platform aims to optimize case processing and safety data management, particularly for post-authorization safety studies.

In April 2024, Qinecsa, a UK-based company, acquired Insife ApS for an undisclosed amount. This strategic acquisition is intended to strengthen Qinecsa's offerings in end-to-end pharmacovigilance technology solutions, aligning with its ambition to become a leading provider in the digital pharmacovigilance sector. Insife ApS is a Denmark-based company specializing in pharmacovigilance software.

Major companies operating in the pharmacovigilance and drug safety software market are Accenture plc, International Business Machines Corporation, Deloitte Touche Tohmatsu Limited, Oracle Corporation, Capgemini SE, Cognizant Technology Solutions, IQVIA, Wipro Limited, Genepact, Parexel Academy, PharmaLex, Indegene Limited, RXLogix, Sarjen Systems Pvt Ltd, Anju Software Inc., Ennov Group, EXTEDO GmbH, ArisGlobal, AB Cube, Clinevo Technologies

North America was the largest region in the pharmacovigilance and drug safety software market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacovigilance and drug safety software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacovigilance and drug safety software market includes revenues earned by entities by signal detection and management tools, risk assessment, and management software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacovigilance And Drug Safety Software Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmacovigilance and drug safety software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacovigilance and drug safety software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmacovigilance and drug safety software market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Software Type: Adverse Event Reporting Software; Drug Safety Audits Software; Issue Tracking Software; Fully Integrated Software
  • 2) By Delivery Mode: On-premise; Cloud-based
  • 3) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Business Process Outsourcing Firms; Other End Users
  • Companies Mentioned: Accenture plc; International Business Machines Corporation; Deloitte Touche Tohmatsu Limited; Oracle Corporation; Capgemini SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmacovigilance And Drug Safety Software Market Characteristics

3. Pharmacovigilance And Drug Safety Software Market Trends And Strategies

4. Pharmacovigilance And Drug Safety Software Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharmacovigilance And Drug Safety Software Market Size and Growth

  • 5.1. Global Pharmacovigilance And Drug Safety Software Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmacovigilance And Drug Safety Software Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmacovigilance And Drug Safety Software Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmacovigilance And Drug Safety Software Market Segmentation

  • 6.1. Global Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Adverse Event Reporting Software
  • Drug Safety Audits Software
  • Issue Tracking Software
  • Fully Integrated Software
  • 6.2. Global Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • On-premise
  • Cloud-based
  • 6.3. Global Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations
  • Business Process Outsourcing Firms
  • Other End Users

7. Pharmacovigilance And Drug Safety Software Market Regional And Country Analysis

  • 7.1. Global Pharmacovigilance And Drug Safety Software Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmacovigilance And Drug Safety Software Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmacovigilance And Drug Safety Software Market

  • 8.1. Asia-Pacific Pharmacovigilance And Drug Safety Software Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmacovigilance And Drug Safety Software Market

  • 9.1. China Pharmacovigilance And Drug Safety Software Market Overview
  • 9.2. China Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmacovigilance And Drug Safety Software Market

  • 10.1. India Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmacovigilance And Drug Safety Software Market

  • 11.1. Japan Pharmacovigilance And Drug Safety Software Market Overview
  • 11.2. Japan Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmacovigilance And Drug Safety Software Market

  • 12.1. Australia Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmacovigilance And Drug Safety Software Market

  • 13.1. Indonesia Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmacovigilance And Drug Safety Software Market

  • 14.1. South Korea Pharmacovigilance And Drug Safety Software Market Overview
  • 14.2. South Korea Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmacovigilance And Drug Safety Software Market

  • 15.1. Western Europe Pharmacovigilance And Drug Safety Software Market Overview
  • 15.2. Western Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmacovigilance And Drug Safety Software Market

  • 16.1. UK Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmacovigilance And Drug Safety Software Market

  • 17.1. Germany Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmacovigilance And Drug Safety Software Market

  • 18.1. France Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmacovigilance And Drug Safety Software Market

  • 19.1. Italy Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmacovigilance And Drug Safety Software Market

  • 20.1. Spain Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmacovigilance And Drug Safety Software Market

  • 21.1. Eastern Europe Pharmacovigilance And Drug Safety Software Market Overview
  • 21.2. Eastern Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmacovigilance And Drug Safety Software Market

  • 22.1. Russia Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmacovigilance And Drug Safety Software Market

  • 23.1. North America Pharmacovigilance And Drug Safety Software Market Overview
  • 23.2. North America Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmacovigilance And Drug Safety Software Market

  • 24.1. USA Pharmacovigilance And Drug Safety Software Market Overview
  • 24.2. USA Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmacovigilance And Drug Safety Software Market

  • 25.1. Canada Pharmacovigilance And Drug Safety Software Market Overview
  • 25.2. Canada Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmacovigilance And Drug Safety Software Market

  • 26.1. South America Pharmacovigilance And Drug Safety Software Market Overview
  • 26.2. South America Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmacovigilance And Drug Safety Software Market

  • 27.1. Brazil Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmacovigilance And Drug Safety Software Market

  • 28.1. Middle East Pharmacovigilance And Drug Safety Software Market Overview
  • 28.2. Middle East Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmacovigilance And Drug Safety Software Market

  • 29.1. Africa Pharmacovigilance And Drug Safety Software Market Overview
  • 29.2. Africa Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmacovigilance And Drug Safety Software Market Competitive Landscape And Company Profiles

  • 30.1. Pharmacovigilance And Drug Safety Software Market Competitive Landscape
  • 30.2. Pharmacovigilance And Drug Safety Software Market Company Profiles
    • 30.2.1. Accenture plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. International Business Machines Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Deloitte Touche Tohmatsu Limited
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Oracle Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Capgemini SE
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharmacovigilance And Drug Safety Software Market Other Major And Innovative Companies

  • 31.1. Cognizant Technology Solutions
  • 31.2. IQVIA
  • 31.3. Wipro Limited
  • 31.4. Genpact
  • 31.5. Parexel Academy
  • 31.6. PharmaLex
  • 31.7. Indegene Limited
  • 31.8. RXLogix
  • 31.9. Sarjen Systems Pvt Ltd
  • 31.10. Anju Software Inc.
  • 31.11. Ennov Group
  • 31.12. EXTEDO GmbH
  • 31.13. ArisGlobal
  • 31.14. AB Cube
  • 31.15. Clinevo Technologies

32. Global Pharmacovigilance And Drug Safety Software Market Competitive Benchmarking

33. Global Pharmacovigilance And Drug Safety Software Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmacovigilance And Drug Safety Software Market

35. Pharmacovigilance And Drug Safety Software Market Future Outlook and Potential Analysis

  • 35.1 Pharmacovigilance And Drug Safety Software Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharmacovigilance And Drug Safety Software Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharmacovigilance And Drug Safety Software Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer